Download - TAKE HOME MESSAGE
![Page 1: TAKE HOME MESSAGE](https://reader035.vdocuments.net/reader035/viewer/2022081512/56814209550346895dadf3d7/html5/thumbnails/1.jpg)
TAKE HOME MESSAGETAKE HOME MESSAGE
TAKE HOME MESSAGES
![Page 2: TAKE HOME MESSAGE](https://reader035.vdocuments.net/reader035/viewer/2022081512/56814209550346895dadf3d7/html5/thumbnails/2.jpg)
HbA1c: hoe goed waren we en zijn we geworden?
Jaar Afwijking Intralab Interlab Target CV CV
1993 ---- 5.2% 22.0%
1999 +0.3% 4.9% 11.2%
2002 -0.1% 3.4% 8.5%
2003 -0.2% 2.9% 6.9%
2004 +0.1% 2.6% 4.8%
Compliment aan de Labs en ManufacturersBron: C.W Weykamp
![Page 3: TAKE HOME MESSAGE](https://reader035.vdocuments.net/reader035/viewer/2022081512/56814209550346895dadf3d7/html5/thumbnails/3.jpg)
Glucose (Combi Algemene Chemie) mol/LGlucose (Combi Algemene Chemie) mol/L Ronde 2008.1Ronde 2008.1Gebruikte methodesGebruikte methodes AantalAantal
GDHGDH 1414
GODGOD 4040
HKHK 140140
OverallOverall GDHGDH GODGOD HKHK
Concentratie monster 2Concentratie monster 2 3,93,9 4,04,0 3,93,9 3,93,9
Tussenlab CV in %Tussenlab CV in % 3,03,0 4,04,0 2,72,7 3,13,1
Concentratie monster 1Concentratie monster 1 10,410,4 10,610,6 10,410,4 10,410,4
Tussenlab CV in %Tussenlab CV in % 2,92,9 2,62,6 2,52,5 2,92,9
Concentratie monster 4Concentratie monster 4 16,916,9 17,217,2 16,916,9 16,816,8
Tussenlab CV in %Tussenlab CV in % 2,72,7 3,33,3 2,62,6 2,72,7
![Page 4: TAKE HOME MESSAGE](https://reader035.vdocuments.net/reader035/viewer/2022081512/56814209550346895dadf3d7/html5/thumbnails/4.jpg)
Microalbumine (Combi Urine) mg/LMicroalbumine (Combi Urine) mg/L Ronde 2008.1Ronde 2008.1
Gebruikte methodesGebruikte methodes AantalAantal
INAINA 1919
ITAITA 128128
OverallOverall INAINA ITAITA
Concentratie monster FConcentratie monster F 3,53,5 3,83,8 3,43,4
Tussenlab CV in %Tussenlab CV in % 34,334,3 21,121,1 35,335,3
Concentratie monster BConcentratie monster B 10,910,9 12,112,1 10,710,7
Tussenlab CV in %Tussenlab CV in % 20,220,2 9,19,1 21,521,5
Concentratie monster EConcentratie monster E 2525 25,325,3 2525
Tussenlab CV in %Tussenlab CV in % 8,88,8 7,97,9 8,88,8
![Page 5: TAKE HOME MESSAGE](https://reader035.vdocuments.net/reader035/viewer/2022081512/56814209550346895dadf3d7/html5/thumbnails/5.jpg)
Standardization in Standardization in Laboratory Medicine:Laboratory Medicine:
are the times changing?are the times changing?
![Page 6: TAKE HOME MESSAGE](https://reader035.vdocuments.net/reader035/viewer/2022081512/56814209550346895dadf3d7/html5/thumbnails/6.jpg)
![Page 7: TAKE HOME MESSAGE](https://reader035.vdocuments.net/reader035/viewer/2022081512/56814209550346895dadf3d7/html5/thumbnails/7.jpg)
![Page 8: TAKE HOME MESSAGE](https://reader035.vdocuments.net/reader035/viewer/2022081512/56814209550346895dadf3d7/html5/thumbnails/8.jpg)
EQA provider / SKML EQA provider / SKML chemistry section:chemistry section:post-market vigilance of post-market vigilance of analytical performanceanalytical performancetools:tools: harmonizers /harmonizers / trueness controls trueness controls
Clinical chemistClinical chemistin case of excessive bias: in case of excessive bias: temporary (re)calibrationtemporary (re)calibrationtools:tools: matrix-based matrix-based reference materials reference materials
ManufacturerManufacturer& directive 98/79/EC& directive 98/79/ECon IVD-MD & JCTLMon IVD-MD & JCTLM
Traceability Traceability chainchain
CLUE =
commutability
![Page 9: TAKE HOME MESSAGE](https://reader035.vdocuments.net/reader035/viewer/2022081512/56814209550346895dadf3d7/html5/thumbnails/9.jpg)
Standardization Standardization in Laboratory in Laboratory
Medicine:Medicine:
the times have the times have changed!changed!
![Page 10: TAKE HOME MESSAGE](https://reader035.vdocuments.net/reader035/viewer/2022081512/56814209550346895dadf3d7/html5/thumbnails/10.jpg)
![Page 11: TAKE HOME MESSAGE](https://reader035.vdocuments.net/reader035/viewer/2022081512/56814209550346895dadf3d7/html5/thumbnails/11.jpg)
En wat Bokito lukte,zal ons ook lukken….……eens
En wat Bokito lukte,zal ons ook lukken….……eens